Cubist Systematic Strategies, LLC Novavax Inc Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Novavax Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 94,000 shares of NVAX stock, worth $682,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,000

Previous 99,300 5.34%

Holding current value

$682,440

Previous $798,000 24.56%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $351,815 - $502,141	-52,746 Reduced 99.43%	301 $2,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $2.52 Million - $5.46 Million	-437,703 Reduced 89.19%	53,047 $367,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $4.17 Million - $11.8 Million	471,178 Added 2407.41%	490,750 $5.04 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $126,308 - $528,272	-6,940 Reduced 26.18%	19,572 $356,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $986,308 - $2.05 Million	-27,186 Reduced 50.63%	26,512 $1.36 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $2.01 Million - $4.12 Million	28,836 Added 115.98%	53,698 $3.96 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $2.99 Million - $4.84 Million	22,208 Added 836.77%	24,862 $3.56 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $1.88 Million - $2.87 Million	-10,600 Reduced 79.98%	2,654 $550,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $1.01 Million - $2.16 Million	8,379 Added 171.88%	13,254 $2.81 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $115,804 - $327,928	-1,025 Reduced 17.37%	4,875 $884,000
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $227,794 - $403,573	-2,893 Reduced 32.9%	5,900 $658,000
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $464,485 - $1.04 Million	5,847 Added 198.47%	8,793 $953,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $40,831 - $246,315	2,946 New	2,946 $246,000

Others Institutions Holding NVAX

# of Institutions

299

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $568M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Novavax Inc Transaction History